Contents

Current Cancer Drug Targets, Volume 10 - Number 1






Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting

, 10(1): 46 - 54

D. Santini, V. Virzi, M. E. Fratto, F. Bertoldo, R. Sabbatini, R. Berardi, N. Calipari, D. Ottaviani and T. Ibrahim


DOI: 10.2174/156800910790980223




CETUXIMAB: From Bench to Bedside

, 10(1): 80 - 95

B. Vincenzi, A. Zoccoli, F. Pantano, O. Venditti and S. Galluzzo


DOI: 10.2174/156800910790980241






Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science